RADIESSE®(+) 1.5ml w/ Lidocaine

Where can I buy this product?

RADIESSE® (+) 1.5ml w/ Lidocaine is available for purchase through Health Supplies Plus by licensed medical practitioners holding a valid medical license. First-time buyers can register an online account by providing required professional information, including medical license verification and a valid shipping address. Account verification is typically completed within 2 business hours, after which you can purchase medical supplies at competitive wholesale pricing. Registered members may also be eligible for volume discounts and receive dedicated customer service support. We are committed to ensuring all products are sourced and sold exclusively to qualified professionals.

Product Information

What is RADIESSE® (+) 1.5ml w/ Lidocaine?

RADIESSE® (+) 1.5ml w/ Lidocaine is a sterile, injectable, subdermal implant manufactured by Merz Aesthetics. It is composed of synthetic Calcium Hydroxylapatite (CaHA) microspheres (approximately 30%) suspended in an aqueous carboxymethylcellulose gel carrier (approximately 70%), with the addition of 0.3% lidocaine hydrochloride to enhance patient comfort during the injection procedure. This formulation is designed for soft tissue augmentation, offering both immediate volumization and sustained biostimulation.

RADIESSE® (+) is intended for injection into the deep dermis or subdermis to correct moderate to severe facial wrinkles and folds (such as nasolabial folds), restore facial volume (e.g., cheeks, temples, jawline), and for correcting volume loss in the dorsum of the hands. **It is critical to note that Radiesse® is a CaHA-based filler and is NOT reversible with hyaluronidase.**

Storage: Store according to manufacturer guidelines, typically at controlled room temperature between 15°C and 25°C (59°F and 77°F). Do not freeze. Protect from light.

Authenticity: Health Supplies Plus guarantees that all RADIESSE® products sourced are authentic from the manufacturer or authorized distributors.

Note: For professional use only by trained and licensed practitioners experienced in the use of CaHA fillers and deep injection techniques.

How does RADIESSE® (+) 1.5ml w/ Lidocaine work? (Based on Manufacturer Information)

RADIESSE® (+) w/ Lidocaine provides a dual mechanism of action for facial rejuvenation and contouring:

1. Immediate Volumization: Upon injection, the gel carrier immediately adds volume and lift, visibly correcting wrinkles, folds, or contour deficiencies. The integrated lidocaine provides local anesthesia for improved comfort during this process.
2. Neocollagenesis (Collagen Stimulation): Over the subsequent weeks and months, the CaHA microspheres act as a scaffold, stimulating the patient’s own fibroblasts to produce new Type I and Type III collagen. As the gel carrier is naturally absorbed, this newly formed collagen matrix provides durable, natural-looking structural support and continued volume.

This biostimulatory effect results in sustained improvement in skin quality and volume that extends beyond the initial filling effect. RADIESSE® is recognized for its high viscosity and elasticity (G’), providing excellent lift capacity and robust support for structural facial contouring.

Treatment results are immediately apparent due to the gel, with ongoing improvement as new collagen forms. The manufacturer suggests a duration of effect often lasting 12 to 18 months, and potentially longer in some individuals, contingent on patient factors, treatment area, and volume injected.

Indications for Use (Common Applications)

Based on its properties and common clinical use (including approved indications in various regions for specific areas), RADIESSE® (+) 1.5ml w/ Lidocaine is typically indicated for adults for:

• Correction of moderate to severe facial wrinkles and folds (e.g., nasolabial folds, marionette lines).
• Facial volume restoration and contouring (e.g., cheeks, temples, pre-jowl sulcus, chin, jawline).
• Correction of volume loss in the dorsum of the hands.
• Addressing facial lipoatrophy in appropriate patient populations.

It requires deep dermal or subcutaneous injection techniques. Appropriate patient selection, comprehensive anatomical knowledge, and consideration of contraindications outlined in the product guidelines are crucial.

Primary Benefits (Based on Manufacturer Claims & Clinical Use)

• Provides immediate volume correction and long-term collagen biostimulation.
• High viscosity and elasticity offer excellent lift and structural support.
• Versatile for treating deep wrinkles, folds, and restoring facial/hand volume.
• Durable results, often lasting 12-18 months or more.
• Biocompatible CaHA microspheres are gradually metabolized by the body.
• Contains 0.3% lidocaine for enhanced patient comfort during injection.
• Well-established product with an extensive history of clinical use.

Side Effects and Safety Information

Practitioners must obtain and consult the complete product guidelines provided by the manufacturer for comprehensive details on administration, contraindications, warnings, precautions, and potential adverse events before using this product. Discussing all potential risks and side effects with patients is essential, including its non-reversible nature with hyaluronidase. Advanced training in deep injection techniques and thorough anatomical knowledge are mandatory for safe use.

Common side effects expected with CaHA filler injections include temporary, injection-site related reactions:

• Swelling (can be significant initially)
• Bruising / Ecchymosis
• Redness / Erythema
• Tenderness or Pain
• Itching
• Firmness or Palpable Lumps/Bumps (CaHA nodules may require specific management)
• Nodules

Severe Adverse Events:
Injecting deep, structural fillers carries significant risks. Practitioners must be prepared to manage serious complications. Potential severe adverse events include:

• Vascular Occlusion (VO): Accidental injection into a blood vessel can obstruct blood flow, potentially leading to severe tissue necrosis, scarring, or (in rare cases involving facial arteries) blindness or stroke. As Radiesse is not reversible with hyaluronidase, prevention through meticulous technique and appropriate VO management protocols (excluding hyaluronidase as a primary solvent for the CaHA component) are even more critical.
• Severe allergic reactions or hypersensitivity to components (including lidocaine if present)
• Inflammation, infection, or abscess formation
• Nodule or granuloma formation (CaHA nodules may require different management strategies than HA nodules, e.g., intralesional steroids, surgical excision in refractory cases).
• Migration of microspheres (rare)
• Prolonged pain or numbness
• Herpetic eruptions (cold sores) in susceptible individuals
• Needle jamming (rare, can be related to product viscosity/handling)

Any signs of vascular compromise, infection, hypersensitivity, or persistent adverse reactions require immediate medical evaluation and management according to established best practices.